Teva Pharmaceutical Industries (NYSE:TEVA) earnings and shareholder returns have been trending downwards for the last five years, but the stock lifts 3.6% this past week
Is Teva Pharmaceutical Industries Limited's (NYSE:TEVA) 4.1% ROE Worse Than Average?
Yahoo Finance Stock Info Extractor
TEVA Gears Up to Report Q4 Earnings: What's in the Cards?